3,303 followers
Teriparatide reduced fracture prevalence to similar levels as in the general population at 10 years’ follow-up. HRQoL was low in osteoporosis and unaffected by bone specifc treatment. G Kontogeorgos et al. BMC Musculoskelet Disord 2022 Nov 24 https://t.co/